AKU patients carry homozygous or compound heterozygous mutations of the HGD gene leading to a deficiency of the enzyme homogentisate 1,2-dioxygenase (HGD), which is involved in the catabolic pathway of tyrosine [4, 5]. The gene discussed is HGD; the disease is alkaptonuria.